All the news Showing 5 of 5 articles from: Russian FederationGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis D Myrcludex B plus tenofovir suppresses hepatitis delta Liz Highleyman / 30 April 2018 An experimental drug that blocks the entry of hepatitis B virus (HBV) and hepatitis delta virus (HDV) into liver cells suppressed HBV and HDV levels and led to improvement in ... Treatment outcomes Real-world studies show 8-week sofosbuvir/ledipasvir course just as effective as 12-week course for genotype 1 patients without cirrhosis Keith Alcorn / 02 December 2016 An 8-week course of treatment with sofosbuvir/ledipasvir is just as effective as a 12-week course of treatment in people without cirrhosis, including those with HIV/hepatitis C virus (HCV) co-infection, and could significantly reduce ... Access to medicines & diagnostics Generic hepatitis C drugs purchased online achieve high cure rates Keith Alcorn / 27 October 2016 Use of generic versions of direct-acting antivirals resulted in very high cure rates for people who obtained the products through three buyers’ clubs, indicating that the generic products are effective, according to three ... Hepatitis delta Prolonged pegylated interferon plus tenofovir does not prevent hepatitis delta relapse Liz Highleyman / 23 April 2014 Treating hepatitis B patients with hepatitis delta virus (HDV) co-infection using pegylated interferon plus tenofovir (Viread) for 96 weeks may reduce HDV viral load, but side-effects are frequent and it did not significantly improve ... Access to medicines & diagnostics Hepatitis C treatment gap in Europe: France doing well but Italy treated fewer than one in a hundred patients in 2010 Caspar Thomson / 23 May 2013 France led the world in the proportion of its hepatitis C patients who received treatment in 2010, but some countries in southern and eastern Europe had treatment rates that were almost tenfold ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive